Micronization: A method of improving the bioavailability of poorly soluble drugs

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 3, 1998, Pages 211-215

  Chaumeil, J C ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Diosmin; Griseofulvin; Micronization; Progesterone; Spironolactone

Indexed keywords

DIOSMIN; GRISEOFULVIN; PROGESTERONE; SPIRONOLACTONE;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SOLUBILITY; PARTICLE SIZE;

BIOLOGICAL AVAILABILITY; DIOSMIN; DRUG COMPOUNDING; GRISEOFULVIN; PARTICLE SIZE; PROGESTERONE; SOLUBILITY; SPIRONOLACTONE;

EID: 0031859673     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Le Hir, A. Pharmacie galénique, Bonnes pratiques de fabrication. 7th Edition. Masson: Paris 1997, 275-88.
2. European Pharmacopea. 3rd Edition.
3. Nyström, C., Mazur, J., Barnett, M.I., Glazer, M. Physicochemical aspects of drug release. I. Dissolution rate measurements of sparingly soluble compounds with the Coulter Counter TA II. J Pharm Pharmacol 1985, 37: 217-21.
4. Sjôkvist, E., Nyström, C., Alden, M. Physicochemical aspects of drug release. IX. Investigation of some factors that impair dissolution of drugs form particulate dispersion systems, Int J Pharm 1989, 54: 161-70.
5. Sitruk-Ware, R., Bricaire, C., De Lignieres, B., Yaneva, H., Mauvais-Jarvis, P. Oral micronized progesterone. Contraception 1987, 36: 373-85.
6. Simon, J.A., Robinson, D.E., Andrews, M.C., Hildebrand, J.R., Rocci Jr., M.L., Blake, R.E., Hodgen, G.D. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil Steril 1993, 60: 26-33.
7. Clarke, J.M., Ramsay, L.E., Shelton, J.R., Tidd, M.J., Murray, S., Palmer, R.F. Factors influencing comparative bioavailability of spironolactone tablets. J Pharm Sci 1977, 66: 1429-32.
8. McInnes, G.T., Asbury, M.J., Ramsay, E.R., Shelton, J.R. Effect of micronization on the bioavailability and activity of spironolactone. J Clin Pharmacol 1982, 22: 410-7.
9. Johnston, A.M., Paul, H.J., Young, C.G. Effects of micronization on digestive absorption of diosmin. Phlebology 1994(Suppl 1): 4-6.
10. Cospite, M., Dominici, A. Double-blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Int Angiol 1989, 8(Suppl 4): 61-5.